H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

In new studies, researchers concluded that licorice triterpenoids could be candidates for anti-SARS-CoV-2 drug developments.

2 Dec 2021

Novel influenza vaccine candidate shows promise

Researchers investigate the potential value of a new vaccine candidate for the influenza virus.

29 Nov 2021

How often does SARS-CoV-2 infect alongside another viruses?

Researchers have been exploring data from COVID-19 patients tested at hospitals or clinics that also look for evidence of other diseases.

28 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

A new study, published on the bioRxiv* preprint server, has discovered a class of new immunostimulatory RNAs while studying influenza infection-associated host genes in human lung epithelial cells using small interfering RNAs (siRNAs). Scientists revealed that these short duplex RNAs could induce type I and type III interferons (IFN-I/III) in a wide variety of cells.

23 Nov 2021

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

A novel study is assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.

12 Nov 2021

SARS-CoV-2 infection regulates protein arginylation

A new study explores the role of arginylation during SARS-CoV-2 infection.

9 Nov 2021

SARS-CoV-2 infection in white-tailed deer

In the current study, SARS-CoV-2 antibodies were identified in over a third of free-ranging deer in northeast Ohio.

9 Nov 2021

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Researchers have tried to develop an innovative platform for ultrasensitive and rapid detection of SARS-CoV-2 by exploiting a variation of Raman Spectroscopy.

4 Nov 2021

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Researchers evaluate the safety and immunogenicity of an influenza vaccine and mRNA-based COVID-19 vaccine that were administered concomitantly.

3 Nov 2021

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.

3 Nov 2021

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

A new review discusses how molecular and structural biology have contributed to our understanding of antibody recognition of HIV-1, SARS-CoV-2, and Zika.

1 Nov 2021

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Researchers emphasize that an effective vaccine should induce mucosal immunity and prevent the nasal entry of SARS-CoV-2.

27 Oct 2021

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

A study exploring cross-cultural differences in knowledge and attitudes towards COVID-19 reveals that people in Europe had the least knowledge of COVID-19 and lowest tendency to care about the coronavirus, while people in the United States had the lowest tendency to comply with public health restrictions.

20 Oct 2021

Researchers launch new project for improving the ability to predict, respond to future pandemics

A multidisciplinary national research team led by University of Utah Health scientists has launched a comprehensive review and analysis of data collected about COVID-19 in hopes of improving the nation’s ability to predict, detect, and respond to future pandemics.

20 Oct 2021

H1N1 News and Research

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Novel influenza vaccine candidate shows promise

How often does SARS-CoV-2 infect alongside another viruses?

Using metal nanoparticles to fight SARS-CoV-2

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

SARS-CoV-2 infection regulates protein arginylation

SARS-CoV-2 infection in white-tailed deer

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Study explores cross-cultural differences in knowledge, attitude towards COVID-19

Researchers launch new project for improving the ability to predict, respond to future pandemics

How did the COVID-19 pandemic impact the circulation of other respiratory viruses in New York City?

New study shows how COVID-19 response has impacted the U.S. public health system

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Scientists testify the importance of timely influenza vaccination

Optimizing the treatment of epilepsy patients

Stand Up To Cancer; An Interview with Chris Draft

‘Moving molecule’ therapy for severe spinal cord injury

Latest News